found that Fusobacterium nucleatum significantly reduces m6A modifications in colorectal cancer cells and patient-derived xenograft (PDX) tissues through downregulation of METTL3, leading to enhancement of colorectal cancer aggressiveness (Chen et al., 2022). The gene discussed is METTL3; the disease is colorectal cancer.